Legend Biotech Corporation (LEGN)

NMS – Real Time Price. Currency in USD

20.73

-1.10 (-5.06%)

Market open: Aug 12, 2026, 12:27 PM EDT

21.93

+0.10 (0.46%)

Previous after-hours: Aug 11, 2026, 7:48 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

1.03B

628M

285M

117M

Cost of goods sold

-438M

-258M

-165M

-84M

Gross Profit

593M

369M

120M

33M

Operating expenses (excl. COGS)

-730M

-679M

-562M

-491M

Operating Income

-137M

-310M

-442M

-458M

Non-operating income, total

-146M

152M

-78M

12M

Pretax income

-283M

-158M

-520M

-445M

Equity in earnings

Taxes

-14M

-19M

-624K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-298M

-177M

-518M

-446M

Discontinued operations

Net income

-298M

-177M

-518M

-446M

Dilution adjustment

Preferred dividends

Legend Biotech Corporation (LEGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Legend Biotech Corporation (LEGN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Legend Biotech Corporation (LEGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Legend Biotech Corporation (LEGN)

Income Statement (Annual)

Income Statement (Annual)